ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ELEV Elevation Oncology Inc

3.23
-0.12 (-3.58%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Elevation Oncology Inc ELEV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.12 -3.58% 3.23 23:00:09
Open Price Low Price High Price Close Price Previous Close
3.34 3.15 3.355 3.23 3.35
more quote information »

Recent News

Date Time Source Heading
6/14/202415:15EDGAR2Form 8-K - Current report
5/17/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
5/09/202415:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/07/202406:30PRNUSElevation Oncology to Present at the Citizens JMP Life..
5/02/202406:30PRNUSElevation Oncology Reports First Quarter 2024 Financial..
4/08/202415:30PRNUSElevation Oncology Presents Preclinical Proof-of-Concept..
3/06/202407:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/06/202406:45EDGAR2Form 8-K - Current report
3/06/202406:30PRNUSElevation Oncology Reports Fourth Quarter and Full Year 2023..
3/06/202406:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/202415:50PRNUSElevation Oncology to Present Preclinical Proof-of-Concept..
3/04/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
3/04/202406:30PRNUSElevation Oncology Appoints Experienced Clinical Development..
2/28/202406:30PRNUSElevation Oncology to Participate in Upcoming Investor..
2/22/202406:30PRNUSElevation Oncology Expands Ongoing Phase 1 Clinical Trial of..
2/20/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/23/202415:15EDGAR2Form 8-K - Current report
1/22/202415:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/22/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/22/202415:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/22/202406:45EDGAR2Form 8-K - Current report
1/22/202406:30PRNUSElevation Oncology Announces Appointment of Darcy Mootz,..
1/09/202415:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/05/202406:40EDGAR2Form 8-K - Current report
1/05/202406:30PRNUSElevation Oncology Announces Program Updates and Upcoming..
11/22/202306:30PRNUSElevation Oncology to Present at the Piper Sandler 35th..
11/02/202306:45EDGAR2Form 8-K - Current report
11/02/202306:30PRNUSElevation Oncology Reports Third Quarter 2023 Financial..
11/02/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/22/202315:30EDGAR2Form 8-K - Current report
9/05/202306:30PRNUSElevation Oncology to Present at the H.C. Wainwright 25th..
8/16/202306:45EDGAR2Form 8-K - Current report
8/16/202306:30PRNUSElevation Oncology Announces First Patient Dosed in the..
8/03/202306:45EDGAR2Form 8-K - Current report
8/03/202306:30PRNUSElevation Oncology Reports Second Quarter 2023 Financial..
8/03/202306:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/03/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/14/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/14/202315:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
7/13/202307:15EDGAR2Form 8-K - Current report
7/13/202307:00PRNUSElevation Oncology Appoints Joseph Ferra as Chief Executive..

Your Recent History

Delayed Upgrade Clock